Drug Designing and Biomarkers

A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation along side pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

Drug designing is an ingenious process to seek out new medication centred on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. this sort of modelling is usually mentioned to as computer-aided drug design.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions

Related Conference of Drug Designing and Biomarkers

July 19-20, 2021

25th Global Congress on Biotechnology

Vienna, Austria
August 06-07, 2021

International Conference on Plant Genomics

London, UK
August 13-14, 2021

36th International Conference on Immunology & Immunogenetics

Edinburgh, Scotland
September 13-14, 2021

4th Annual Summit on Cell and Gene Therapy

Prague, Czech Republic
September 22-23, 2021

13th World Congress on Cell and Stem Cell Research

Madrid, Spain
September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
October 18-19, 2021

20th International Conference on Structural Biology

Rome, Italy
November 20-21, 2021

26th World Congress on Industrial Biotechnology

Chicago, USA
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia

Drug Designing and Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in